Atopic Dermatitis clinical trials
- Phase
- Phase 2
- Phase
- Phase 4
- Phase
- Phase 2
- Phase
- Phase 3
- Phase
- Phase 3
- Phase
- Phase 2
- Phase
- Phase 1
- Phase
- Phase 3
- Phase
- Phase 4
- Phase
- Phase 2
- Phase
- Phase 3
- Phase
- Phase 3
- Phase
- Phase 1
- Phase
- Phase 3
- Phase
- Phase 3
Access comprehensive clinical trial information for Atopic Dermatitis through Pure Global AI's free database. This collection includes 784 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 152 trials are actively recruiting participants.
Research for Atopic Dermatitis is being conducted in United States of America, China, Germany and 7+ other countries. Leading sponsors include LEO Pharma and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 784 clinical trials studying Atopic Dermatitis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include LEO Pharma, Eli Lilly and Company, AbbVie, among others.